Appendix 3C - Notification of buy-back Announcement Summary Name of entity ACTINOGEN MEDICAL LIMITED Announcement type Update announcement Type of update Final buy-back notification Date of this announcement 12/11/2026 Reason for update Final buy-back notification ASX Security code and description...
Update - Notification of buy-back - ACW
Filed with ASX · · 6 pages · English
Release
Actinogen Medical Limited on 6ix
Story so far
Earlier from Actinogen Medical
- Response to ASX Price Query
- Letter to Shareholders, Notice of AGM & Proxy Form
- Actinogen receives $10.8m R&D tax incentive rebate from ATO
- ACW pivotal Alzheimers trial database lock - results mid-Nov
- ACW September 2026 quarterly activity report & Appendix 4C
Later from Actinogen Medical
- Notification of cessation of securities - ACW
- Trading Halt
- Request for Trading Halt
- Suspension from Quotation
- ACW XanaMIA Alzheimers trial results
Follow Actinogen Medical into a list and get an email when it puts out news.
Follow Actinogen Medical